Phosphagenics says Nestle Nutrition exercises Phospha-E option |
|
|
|
Published
:
Fri, 12 Jan 2007 10:17
|
LONDON (AFX) - Phosphagenics Ltd said that Nestle AG's Nestle Nutrition has exercised its option under an existing commercial agreement to use vitamin E-based Phospha-E for the treatment and prevention of metabolic syndrome.On Dec 14, Phosphagenics said that it had completed its Phospha-E pre-clinal trial program with Nestle Nutrition, with positive results, and was waiting Nestle's decision on whether to exercise its option to develop the product.Further details will be released once Phosphagenics has received Nestle Nutrition's consent, said the Australian drug delivery company.newsdesk@afxnews.comroCOPYRIGHTCopyright AFX News Limited 2006. All rights reserved.The copying, republication or redistribution of AFX News Content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News.AFX News and AFX Financial News Logo are registered trademarks of AFX News Limited
|
|
|
|
|
|
|
| Stock
Quotes * |
|
NASDAQ
|
|
2792.28 |
22.57 (
0.81 %)
|
| SYMBOL (
2012-01-19 ) |
| LAST |
CHANGE
|
|
CARNIVAL
(
11:35am )
|
|
2017.00 |
46.00 (
2.42 %)
|
|
WHITBREAD
(
11:35am )
|
|
1662.99 |
33.99 (
2.09 %)
|
| SYMBOL (
2012-01-19 )
|
| LAST |
CHANGE
|
|
IBM
(
12:34pm ) |
|
181.50 |
0.43 (
0.24 %)
|
| SYMBOL (
2012-01-19 )
|
| LAST |
CHANGE
|
|
|
Print this Story
Nestle 10 pct organic growth/yr in nutrition unit, seeks acquisitions 